Molecule Structure

Scientific Name


Description of the Drug

Buserelin is a LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Suprecur, Suprefact

Company Owner(s)

Not Available

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Gonadotropin-releasing hormone receptor SINGLE PROTEIN AGONIST CHEMBL1855

Unichem Links

SureChEMBL SCHEMBL19459955 SCHEMBL19409318 SCHEMBL13354
DrugBank DB06719
PubChem: Thomson Pharma 14792674 16007031 16901273
PubChem 50225
Nikkaji J14.642K
DrugCentral 436
ChemicalBook CB9287695 CB6287694
Guide to Pharmacology 3860
ChEBI 135907